182781842	182781842	CD	B-NP	O
|	|	NN	I-NP	O
OH	OH	NN	I-NP	O
|	|	NN	I-NP	O
49695934	49695934	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6096860	6096860	CD	B-NP	O
|	|	CC	I-NP	O
10/16/2004	10/16/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Congestive	Congestive	NNP	I-NP	O
Heart	Heart	NNP	I-NP	O
Failure	Failure	NNP	I-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/11/2004	5/11/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/19/2004	6/19/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
TURTURO	TURTURO	NN	B-NP	O
,	,	,	O	O
RAYFORD	RAYFORD	NN	B-NP	O
550-19-26-3	550-19-26-3	CD	I-NP	O
Reve	Reve	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
9/14/04	9/14/04	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CORKERN	CORKERN	NNP	B-NP	O
,	,	,	O	O
ROBERTO	ROBERTO	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/23/04	9/23/04	CD	B-NP	O
by	by	IN	B-PP	O
JAHNS	JAHNS	NN	B-NP	B-protein
,	,	,	O	O
WINFRED	WINFRED	VBD	B-VP	O
M	M	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
WARFARIN	WARFARIN	NN	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
26995098	26995098	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	VB	B-VP	O
on	on	RP	B-PRT	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

ALLOPURINOL	ALLOPURINOL	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/23/04	9/23/04	CD	B-NP	O
by	by	IN	B-PP	O
ZORRILLA	ZORRILLA	NNP	B-NP	O
,	,	,	O	O
OMAR	OMAR	NNP	B-NP	O
C	C	NNP	I-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ALLOPURINOL	ALLOPURINOL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
DIGOXIN	DIGOXIN	NNP	B-NP	O
0.125	0.125	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/23/04	9/23/04	CD	B-NP	O
by	by	IN	B-PP	O
BEGUN	BEGUN	NNP	B-NP	O
,	,	,	O	O
LANNY	LANNY	NNP	B-NP	O
E	E	NNP	I-NP	O
F.	F.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOXYL	LEVOXYL	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
66437927	66437927	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DIGOXIN	DIGOXIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpt	outpt	JJ	I-NP	O
LEVOXYL	LEVOXYL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
75	75	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/23/04	9/23/04	CD	B-NP	O
by	by	IN	B-PP	O
CUZCO	CUZCO	NNP	B-NP	O
,	,	,	O	O
JAMISON	JAMISON	NNP	B-NP	O
D	D	NNP	I-NP	O
V.	V.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
WARFARIN	WARFARIN	NN	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
26995098	26995098	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	VB	B-VP	O
on	on	RP	B-PRT	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/23/04	9/23/04	CD	B-NP	O
by	by	IN	B-PP	O
BRIDGETTE	BRIDGETTE	NNP	B-NP	O
,	,	,	O	O
OSWALDO	OSWALDO	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DIGOXIN	DIGOXIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpt	outpt	JJ	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SUST	SUST	NNP	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

50	50	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
8	8	CD	B-NP	O
NEURONTIN	NEURONTIN	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
GABAPENTIN	GABAPENTIN	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
200	200	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
COZAAR	COZAAR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LOSARTAN	LOSARTAN	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Number	Number	NN	I-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
9	9	CD	B-NP	O
CELEXA	CELEXA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CITALOPRAM	CITALOPRAM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
3	3	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
11/24	11/24	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/14/04	4/14/04	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	VB	B-VP	O
on	on	RP	B-PRT	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
LIPITOR	LIPITOR	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
ATORVASTATIN	ATORVASTATIN	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
PRILOSEC	PRILOSEC	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
TORSEMIDE	TORSEMIDE	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QAM	QAM	NNP	I-NP	I-protein
TORSEMIDE	TORSEMIDE	NNP	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QPM	QPM	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Wilfinger	Wilfinger	NNP	I-NP	O
,	,	,	O	O
PCP	PCP	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
weeks	week	NNS	I-NP	I-protein
,	,	,	O	O
Corey	Corey	NNP	B-NP	O
Ortmeyer	Ortmeyer	NNP	I-NP	O
,	,	,	O	O
CHF	CHF	NNP	B-NP	O
clinic	clinic	NN	I-NP	O
,	,	,	O	O
Laxo	Laxo	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
10	10	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
am	am	NN	I-NP	O
1/28/04	1/28/04	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Salvatore	Salvatore	NNP	B-NP	O
Angeli	Angeli	NNP	I-NP	O
,	,	,	O	O
pacer/icd	pacer/icd	NN	B-NP	B-protein
clinic	clinic	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
:	:	:	O	I-protein
30	30	CD	B-NP	I-protein
am	am	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
902	902	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	I-protein
847	847	CD	I-NP	I-protein
06276/6	06276/6	CD	I-NP	I-protein
/	/	SYM	B-NP	O
04	04	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
check	check	NN	I-NP	I-protein
at	at	IN	B-PP	O
regular	regular	JJ	B-NP	O
location	location	NN	I-NP	O
1/28/04	1/28/04	CD	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
SHRIMP	SHRIMP	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
Heart	Heart	NN	I-NP	O
Failure	Failure	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Congestive	Congestive	NNP	I-NP	O
Heart	Heart	NNP	I-NP	O
Failure	Failure	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
Adriamycin	Adriamycin	NN	I-NP	O
induced	induce	VBD	B-VP	O
CMP	CMP	NN	B-NP	B-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
IDDM	IDDM	NN	B-NP	O
,	,	,	O	O
Sarcoid	Sarcoid	NN	B-NP	O
,	,	,	O	O
Left	Left	NNP	B-NP	O
Breast	Breast	NNP	I-NP	O
CA	CA	NN	I-NP	O
-	-	HYPH	B-NP	O
s/p	s/p	NN	I-NP	O
lumpect	lumpect	NN	I-NP	O
and	and	CC	I-NP	O
XRT/Adria	XRT/Adria	NN	I-NP	B-protein
-	-	HYPH	O	I-protein
'84	'84	CD	B-NP	I-protein
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
?	?	.	O	O

GI	GI	NN	B-NP	O
origin	origin	NN	I-NP	O
of	of	IN	B-PP	O
epigastric	epigastric	JJ	B-NP	B-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
dvt	dvt	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
osteoarthritis	osteoarthritis	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
unspecified	unspecified	JJ	B-ADJP	O
or	or	CC	O	O
generalized	generalize	VBN	B-VP	O
OA	OA	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
hypothyroid	hypothyroid	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
VVI/R	VVI/R	NN	B-NP	B-protein
ICD	ICD	NN	I-NP	I-protein
placement	placement	NN	I-NP	I-protein
5/6/4	5/6/4	CD	I-NP	I-protein
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Chan	Chan	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
60	60	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
and	and	CC	I-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
induced	induce	VBD	B-VP	O
CMP	CMP	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
EF	EF	NN	I-NP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
CMP	CMP	NN	B-NP	O
clinic	clinic	NN	I-NP	O
;	;	:	O	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
L	L	NN	I-NP	O
O2	O2	NN	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
DVT	DVT	NN	I-NP	O
now	now	RB	B-VP	O
anticoagulated	anticoagulate	VBN	I-VP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
afib	afib	NN	B-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
presumed	presume	VBN	B-NP	O
CHF	CHF	NN	I-NP	B-DNA
flare	flare	NN	I-NP	I-DNA
.	.	.	O	O

Ms.	Ms.	NNP	B-NP	O
Guerena	Guerena	NNP	I-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	B-DNA
flare	flare	NN	I-NP	I-DNA
and	and	CC	O	O
received	receive	VBD	B-VP	O
intravenous	intravenous	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reponded	reponde	VBD	B-VP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
185	185	CD	I-NP	O
pounds	pound	NNS	I-NP	O
.	.	.	O	O

Ms.	Ms.	NNP	B-NP	O
Kimmell	Kimmell	NNP	I-NP	O
presented	present	VBD	B-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-NP	O
SOB	SOB	NN	I-NP	B-protein
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
discomfort	discomfort	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomitting	vomitting	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
increasing	increase	VBG	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
change	change	NN	B-NP	O
in	in	IN	B-PP	O
number	number	NN	B-NP	O
of	of	IN	B-PP	O
pillows	pillow	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
endorse	endorse	VB	I-VP	O
PND	PND	NN	B-NP	O
present	present	JJ	B-ADJP	O
but	but	CC	O	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebile	afebile	JJ	B-ADJP	O
,	,	,	O	O
inital	inital	JJ	B-ADJP	O
ly	ly	RB	B-ADVP	O
with	with	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
90	90	CD	I-NP	O
's	's	POS	B-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
L.	L.	NN	I-NP	O
BP	BP	NN	I-NP	O
154/84	154/84	CD	I-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
3000	3000	CD	B-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
engorged	engorged	JJ	I-NP	O
,	,	,	I-NP	O
fatty	fatty	JJ	I-NP	O
liver	liver	NN	I-NP	O
,	,	,	O	O
ascites	ascite	NNS	B-NP	O
,	,	,	O	O
pleural	pleural	JJ	B-NP	B-protein
effusions	effusion	NNS	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
not	not	RB	B-VP	O
seen	see	VBN	I-VP	O
on	on	IN	B-PP	O
CXR	CXR	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

A	A	DT	B-NP	O
surgical	surgical	JJ	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
surgeons	surgeon	NNS	I-NP	O
felt	feel	VBD	B-VP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
surgical	surgical	JJ	B-ADJP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
but	but	CC	O	O
rather	rather	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

Hospital	Hospital	NNP	B-NP	O
Course	Course	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Cardiovascular	Cardiovascular	NNP	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pump	Pump	NN	I-NP	O
-	-	HYPH	B-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
diuresed	diurese	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
initially	initially	RB	B-ADVP	O
with	with	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
lasix	lasix	NN	I-NP	O
until	until	IN	B-PP	O
her	her	PRP$	B-NP	O
respiratory	respiratory	JJ	I-NP	O
status	status	NN	I-NP	O
imroved	imrove	VBD	B-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
good	good	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
her	her	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
90	90	CD	I-NP	O
's	's	POS	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
between	between	IN	B-PP	O
94-96	94-96	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
home	home	NN	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
beta	beta	NN	B-NP	O
blocker	blocker	NN	I-NP	O
,	,	,	O	O
angiotension	angiotension	NN	B-NP	O
receptor	receptor	NN	I-NP	O
blocker	blocker	NN	I-NP	O
and	and	CC	I-NP	O
statin	statin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
again	again	RB	I-VP	O
encouraged	encourage	VBN	I-VP	O
to	to	TO	I-VP	O
adhere	adhere	VB	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
low-salt	low-salt	JJ	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	I-NP	O
weight	weight	NN	I-NP	O
herself	herself	PRP	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Torsemide	Torsemide	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
q	q	NN	I-NP	O
am	am	NN	I-NP	O
and	and	CC	O	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
q	q	NN	I-NP	O
pm	pm	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
regimine	regimine	NN	I-NP	O
t	t	NN	I-NP	O
has	have	VBZ	B-VP	O
worked	work	VBN	I-VP	O
will	will	MD	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
f/uw	f/uw	VB	I-VP	O
iht	iht	VB	I-VP	O
the	the	DT	B-NP	O
Naiimo	Naiimo	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Harold	Harold	NNP	I-NP	O
Gohring	Gohring	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
on	on	IN	B-PP	O
5/6	5/6	CD	B-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
am	am	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Rangespo	Rangespo	NNP	B-NP	O
Chica	Chica	NNP	I-NP	O
Li	Li	NNP	I-NP	O
VNA	VNA	NNP	I-NP	O
who	who	WP	B-NP	O
will	will	MD	B-VP	O
assist	assist	VB	I-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
CHF	CHF	NN	I-NP	O
monitoring	monitoring	NN	I-NP	O
and	and	CC	O	O
assess	assess	VB	B-VP	O
her	her	PRP	B-NP	O
for	for	IN	B-PP	O
home	home	NN	B-NP	O
PT	PT	NN	I-NP	O
.	.	.	O	O

b	b	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
Rhythm	Rhythm	NN	I-NP	B-protein
-	-	HYPH	O	O
The	The	DT	B-NP	O
pa	pa	NN	I-NP	O
tient	tient	NN	I-NP	O
is	be	VBZ	B-VP	O
know	know	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
frequent	frequent	JJ	B-NP	O
PVCs	PVC	NNS	I-NP	O
and	and	CC	O	O
non-sustained	non-sustained	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
agian	agian	JJ	B-ADJP	O
noted	note	VBN	B-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
NSVT	NSVT	NN	I-NP	O
and	and	CC	O	O
remains	remain	VBZ	B-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
.	.	.	O	O

We	We	PRP	B-NP	O
obtained	obtain	VBD	B-VP	O
an	an	DT	B-NP	O
electrophysiology	electrophysiology	NN	I-NP	O
consult	consult	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
AICD	AICD	NN	I-NP	O
or	or	CC	I-NP	O
biventricular	biventricular	JJ	I-NP	O
pacing	pacing	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patietns	patietn	NNS	I-NP	O
electrolytes	electrolyte	NNS	I-NP	O
and	and	CC	I-NP	O
magnesium	magnesium	NN	I-NP	O
were	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
and	and	CC	O	O
rempleted	remplete	VBN	B-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
beta	beta	NN	I-NP	O
blocker	blocker	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
2/14	2/14	CD	B-NP	O
the	the	DT	B-NP	O
EP	EP	NN	I-NP	O
service	service	NN	I-NP	O
placed	place	VBD	B-VP	O
a	a	DT	B-NP	O
VVI/R	VVI/R	NN	I-NP	O
ICD	ICD	NN	I-NP	O
device	device	NN	I-NP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
interogated	interogate	VBN	I-VP	O
ont	ont	IN	B-PP	O
he	he	PRP	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
d/c	d/c	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patietn	patietn	NN	I-NP	O
was	be	VBD	B-VP	O
provided	provide	VBN	I-VP	O
with	with	IN	B-PP	O
written	write	VBN	B-NP	O
instructions	instruction	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
EP	EP	NN	I-NP	O
service	service	NN	I-NP	O
for	for	IN	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Cradduck	Cradduck	NNP	I-NP	O
on	on	IN	B-PP	O
10/30	10/30	CD	B-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
.	.	.	O	O

c	c	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
.	.	.	O	O

ED	ED	VBN	B-VP	O
initially	initially	RB	B-ADVP	O
concerned	concern	VBN	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
o	o	NN	B-NP	O
ut	ut	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
with	with	IN	B-PP	O
negative	negative	JJ	B-NP	B-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
x	x	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Serial	Serial	NNP	B-NP	O
EKG	EKG	NNP	I-NP	O
's	's	POS	B-NP	O
were	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O

We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
beta	beta	NN	B-NP	O
blocker	blocker	NN	I-NP	O
,	,	,	O	O
s	s	VBZ	B-VP	O
tatin	tatin	NN	B-NP	O
and	and	CC	I-NP	O
ARB	ARB	NN	I-NP	B-protein
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Heme	Heme	NNP	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Egerton	Egerton	NNP	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
DVT	DVT	NN	B-NP	O
,	,	,	O	O
therapeutic	therapeutic	JJ	B-ADJP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
did	do	VBD	B-VP	O
decreased	decrease	VBD	B-VP	O
her	her	PRP$	B-NP	O
dose	dose	NN	I-NP	O
while	while	IN	B-SBAR	O
being	be	VBG	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
her	her	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
EP	EP	NN	I-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
d/c	d/c	NN	B-NP	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
resuming	resume	VBG	I-VP	O
her	her	PRP$	B-NP	O
regular	regular	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
usualy	usualy	JJ	I-NP	O
JMC	JMC	NN	I-NP	O
lab	lab	NN	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
checked	check	VBD	B-VP	O
on	on	IN	B-PP	O
Thursday	Thursday	NNP	B-NP	O
5/6	5/6	CD	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
ID	ID	NN	I-NP	O
:	:	:	O	O
+	+	SYM	B-NP	O
UA	UA	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
treated	treat	VBN	B-VP	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	JJ	B-NP	O
Last	Last	JJ	I-NP	O
day	day	NN	I-NP	O
was	be	VBD	B-VP	O
11/19/4	11/19/4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cx	cx	NN	I-NP	O
grew	grow	VBD	B-VP	O
citrobacter	citrobacter	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
levo	levo	NN	B-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
UA	UA	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
GI	GI	NN	I-NP	O
:	:	:	O	O
Abdominal	Abdominal	JJ	B-NP	O
discomfort	discomfort	NN	I-NP	O
presumably	presumably	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
hepatic	hepatic	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
CT	CT	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
surgical	surgical	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
elevated	elevated	JJ	I-NP	O
alk	alk	NN	I-NP	O
phos	pho	NNS	I-NP	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
sarcoid	sarcoid	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Endocrine	Endocrine	NNP	I-NP	O
:	:	:	O	O
Continued	Continue	VBN	B-NP	O
levoxyl	levoxyl	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hypothyroid	hypothyroid	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
with	with	IN	B-PP	O
IDDM	IDDM	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
decreased	decrease	VBD	B-VP	O
her	her	PRP$	B-NP	O
lantus	lantus	NN	I-NP	O
dose	dose	NN	I-NP	O
from	from	IN	B-PP	O
50	50	CD	B-NP	O
u	u	NN	I-NP	O
sc	sc	NN	I-NP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
u	u	NN	I-NP	O
sc	sc	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
as	as	IN	B-PP	O
po	po	NN	B-NP	O
intake	intake	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
can	can	MD	B-VP	O
resume	resume	VB	I-VP	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
dose	dose	NN	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
resumes	resume	VBZ	B-VP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
eating	eat	VBG	B-VP	O
habits	habit	NNS	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
General	General	NNP	I-NP	O
:	:	:	O	O
PT	PT	NN	B-NP	O
consulted	consult	VBD	B-VP	O
to	to	TO	I-VP	O
assist	assist	VB	I-VP	O
in	in	IN	B-PP	O
prevention	prevention	NN	B-NP	O
deconditioning	deconditione	VBG	B-VP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

VNA	VNA	NN	B-NP	B-protein
will	will	MD	B-VP	O
evaluate	evaluate	VB	I-VP	O
need	need	NN	B-NP	O
for	for	IN	B-PP	O
home	home	NN	B-NP	O
PT	PT	NN	I-NP	O
services	service	NNS	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Weight	Weight	MD	O	O
yourself	yourself	PRP	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
when	when	WRB	B-ADVP	O
your	your	PRP$	B-NP	O
weight	weight	NN	I-NP	O
increases	increase	VBZ	B-VP	O
2	2	CD	B-NP	O
.	.	.	O	O

Follow-up	Follow-up	NN	B-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
Primary	Primary	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Physician	Physician	NNP	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
3	3	CD	B-NP	O
.	.	.	O	O

Follow-up	Follow-up	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
CHF	CHF	NN	I-NP	O
clinic	clinic	NN	I-NP	O
on	on	IN	B-PP	O
Thursday	Thursday	NNP	B-NP	O
5/6	5/6	CD	I-NP	O
with	with	IN	B-PP	O
Jeffry	Jeffry	NNP	B-NP	O
Vaudrain	Vaudrain	NNP	I-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
am	am	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

New	New	NNP	B-NP	O
Medication	Medication	NNP	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	NNP	B-NP	O
Replaces	Replace	NNPS	I-NP	O
lasix	lasix	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Torsemide	Torsemide	NN	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
po	po	RB	B-ADVP	O
everynight	everynight	RB	I-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Follow-up	Follow-up	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Newsome	Newsome	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
396	396	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
540-2094	540-2094	CD	I-NP	O
3/11	3/11	CD	I-NP	O
at	at	IN	B-PP	O
9	9	CD	B-NP	O
:	:	SYM	O	O
30	30	CD	B-NP	O
am	am	NN	I-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
ICD	ICD	NN	I-NP	B-protein
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Keep	Keep	NN	B-NP	O
appointments	appointment	NNS	I-NP	O
as	as	IN	B-PP	O
outlined	outlined	JJ	B-ADJP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Have	Have	VB	B-VP	O
your	your	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
checked	check	VBD	B-VP	O
on	on	IN	B-PP	O
Friday	Friday	NNP	B-NP	O
5/6	5/6	CD	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Weight	Weight	MD	O	O
yourself	yourself	PRP	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Call	Call	VB	B-VP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
if	if	IN	B-SBAR	O
your	your	PRP$	B-NP	O
weight	weight	NN	I-NP	O
increases	increase	NNS	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Follow	Follow	RB	B-NP	O
written	write	VBN	I-NP	O
EP	EP	NN	I-NP	O
discharge	discharge	NN	I-NP	O
instructions	instruction	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Fort	Fort	NNP	B-NP	O
VNA	VNA	NNP	I-NP	O
will	will	MD	B-VP	O
resume	resume	VB	I-VP	O
services	service	NNS	B-NP	O
adn	adn	NN	I-NP	O
follow	follow	VBP	B-VP	O
pt	pt	NN	B-NP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
assess	assess	NN	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
home	home	NN	B-NP	O
PT	PT	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
HAMON	HAMON	NNP	B-NP	O
,	,	,	O	O
DANIAL	DANIAL	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BJ823	BJ823	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
9/14/04	9/14/04	CD	I-NP	O
@	@	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
06	06	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

